Age-Related Macular Degeneration Past Present & Future - - PowerPoint PPT Presentation

age related macular degeneration
SMART_READER_LITE
LIVE PREVIEW

Age-Related Macular Degeneration Past Present & Future - - PowerPoint PPT Presentation

Age-Related Macular Degeneration Past Present & Future Cynthia J. MacKay, MD Clinical Professor of Ophthalmology Columbia University College of Physicians and Surgeons (Emeritus) Age-related Macular Degeneration (AMD) 1 AMD is #1


slide-1
SLIDE 1

Age-Related Macular Degeneration Past Present & Future

Cynthia J. MacKay, MD Clinical Professor of Ophthalmology Columbia University College of Physicians and Surgeons (Emeritus)

slide-2
SLIDE 2

Age-related Macular Degeneration (AMD)

1 AMD is #1 cause of blindness over 65 2 My risk - 1/3 over 65 3 What are the symptoms 4 Two types: dry (95%) wet (5% 95% of blindness) 5 What causes AMD 6 Present treatment 7 Possible treatment in the future 8 How to decrease your risk

slide-3
SLIDE 3

AMD: SYMPTOMS

1 Loss of detail: reading driving faces 2 Need for more light 3 Difficulty adapting to light/dark 4 Blank spots 5 Decreased color vision – esp. blues 6 Distortion (See ophthalmologist that day)

slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7

Normal Fundus (Back of Eye)

slide-8
SLIDE 8

Normal Retina

Dry Age-Related Macular Degeneration: Drusen & RPE Atrophy

slide-9
SLIDE 9
slide-10
SLIDE 10

A gene for Age-Related Macular Degeneration has been identified* on chromosome one (2005) This may allow for targeted treatment The gene codes for complement factor H *Josephine Hoh at Yale School of Medicine, and colleagues from Yale, Rockefeller University and the National Eye Institute.

slide-11
SLIDE 11

Dry Macular Degeneration What to avoid

Ocuvite/Preservision “Stem Cell Tourism”

slide-12
SLIDE 12

THE FUTURE

1 Complement inhibition: disappointing except for Complement factor I (“gene testing will tailor therapy”) 2 Gene therapy with adenovirus vector: two phase-2 trials of anti-VEGF for wet AMD 3 Long-acting pellets for wet AMD 4 Ongoing trial: high dose (80 mg) Lipitor 5 Reconstruction of RPE by transplant: Gouras, fetal RPE; NEI, 1/16/16, blood cell converted to RPE cell

slide-13
SLIDE 13

RPE Transplant Technique

slide-14
SLIDE 14

Transforming Blood Cell into RPE Cell

slide-15
SLIDE 15

1 Don’t smoke (3-5 times the risk) 2 Diet: vegetables; limit saturated fat 3 Control your weight and blood pressure 4 Check your eyesight daily 5 See your ophthalmologist yearly

DECREASING YOUR RISK OF AMD